These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

365 related items for PubMed ID: 10604047

  • 1. Efficacy on climacteric symptoms of a new estradiol transdermal patch with active matrix in comparison with a reference reservoir patch. Two long-term randomized multicenter parallel-group studies.
    Rovati LC, Schmid K, Giacovelli G, Bonn M, Setnikar I, Wolff F, Genazzani AR.
    Arzneimittelforschung; 1999 Nov; 49(11):933-43. PubMed ID: 10604047
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics of estradiol and of estrone during application of a new 7-day estradiol transdermal patch with active matrix.
    Setnikar I, Rovati LC, Vens-Cappell B, Hilgenstock C.
    Arzneimittelforschung; 1998 Mar; 48(3):275-85. PubMed ID: 9553686
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The effect of a novel vaginal ring delivering oestradiol acetate on climacteric symptoms in postmenopausal women.
    Buckler H, Al-Azzawi F, UK VR Multicentre Trial Group.
    BJOG; 2003 Aug; 110(8):753-9. PubMed ID: 12892687
    [Abstract] [Full Text] [Related]

  • 7. Estradiol and estrone plasma levels during application of three strengths of a 7-day estradiol transdermal patch.
    Setnikar I, Rovati LC, Santoro A, Guillaume M, Mignot A, Renoux A, Gualano V.
    Arzneimittelforschung; 1999 Aug; 49(8):708-15. PubMed ID: 10483519
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of a seven-day, transdermal estradiol drug-delivery system: comparison with conjugated estrogens and placebo. The Transdermal Estradiol Patch Study Group.
    Gordon SF, Thompson KA, Ruoff GE, Imig JR, Lane PJ, Schwenker CE.
    Int J Fertil Menopausal Stud; 1995 Aug; 40(3):126-34. PubMed ID: 7663539
    [Abstract] [Full Text] [Related]

  • 10. An estradiol matrix transdermal system for the prevention of postmenopausal bone loss.
    McKeever C, McIlwain H, Greenwald M, Gupta N, Jayawardene S, Huels G, Roberts M.
    Clin Ther; 2000 Jul; 22(7):845-57. PubMed ID: 10945511
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and tolerability of Menorest 50 compared with Estraderm TTS 50 in the treatment of postmenopausal symptoms. A randomized, multicenter, parallel group study.
    Pornel B, Genazzani AR, Costes D, Dain MP, Lelann L, Vandepol C.
    Maturitas; 1995 Nov; 22(3):207-18. PubMed ID: 8746878
    [Abstract] [Full Text] [Related]

  • 12. Pulsed estrogen therapy: relieving climacteric symptoms, preventing postmenopausal bone loss.
    Palacios S.
    Climacteric; 2002 Jun; 5 Suppl 2():32-9. PubMed ID: 12482109
    [Abstract] [Full Text] [Related]

  • 13. The lipid and clinical effects of sequential transdermal estradiol and estradiol/norethisterone acetate in 674 women.
    Cano A, Calaf J, Molina J.
    Arch Gynecol Obstet; 2003 Oct; 268(4):317-22. PubMed ID: 14504877
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Continuous versus cyclical transdermal estrogen replacement therapy in postmenopausal women: influence on climacteric symptoms, body weight and bleeding pattern.
    Lübbert H, Nauert C.
    Maturitas; 1997 Dec 15; 28(2):117-25. PubMed ID: 9522319
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Efficacy and tolerability of Estraderm MX, a new estradiol matrix patch.
    Bacchi-Modena A, Bolis P, Campagnoli C, De Cicco F, Meschia M, Pansini F, Pisati R, Hüls G.
    Maturitas; 1997 Jul 15; 27(3):285-92. PubMed ID: 9288701
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Splenopeptides for climacteric complaints. Comparison of ovarian stimulation with transdermal estradiol substitution].
    Lauritzen C, Teucher T, Schmitz H.
    Arzneimittelforschung; 1995 Mar 15; 45(3):315-22. PubMed ID: 7741793
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.